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Abstract : The purpose of this study is to examine the effect of intranasal corticosteroid (INCS) administration 
on histamine H1 receptor (H1R) gene expression in the nasal mucosa of healthy participants and the effects of 
dexamethasone on basal and histamine-induced H1R mRNA expression, and histamine-induced phosphorylation 
of extracellular signal-regulated kinase (ERK) in HeLa cells. Sixteen healthy participants were given INCS once 
daily for a week. After pretreatment of dexamethasone, HeLa cells were treated with histamine. Levels of H1R 
mRNA and phosphorylation of ERK were measured using real time PCR and immunoblot analysis, respectively. 
Levels of H1R mRNA in the nasal mucosa of healthy participants receiving INCS was significantly decreased. 
Dexamethasone suppressed basal levels of H1R mRNA, and histamine-induced up-regulation of H1R mRNA and 
ERK phosphorylation in HeLa cells. These data suggested that corticosteroid inhibited both basal transcription 
and histamine-induced transcriptional activation of H1R through its suppression of ERK phosphorylation in the 
signaling pathway involved in H1R gene transcription. It is further suggested that pre-seasonal prophylactic 
administration of INCS suppresses both basal and pollen-induced upregulation of H1R gene expression in the 
nasal mucosa of patients with pollinosis, leading to prevention of the exacerbation of nasal symptoms during 
peak pollen season. J. Med. Invest. 67 : 311-314, August, 2020
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INTRODUCTION
 
Histamine is a major chemical mediator that induces nasal 
allergy symptoms through its binding to histamine H1 receptor 
(H1R) in the development of allergic rhinitis (1). Antihista-
mines, H1R antagonists, are effective for the treatments of 
allergic rhinitis, including pollinosis (2). In Japan, prophylactic 
administration of antihistamines before the onset of pollen 
season is recommended for pollinosis treatment (1), because the 
pre-seasonal administration of antihistamines is more effective 
than post-onset administration in patients with pollinosis (3). 
In our previous study, we used environmental exposure units 
and demonstrated that pre-administration of ebastine, an an-
tihistamine down-regulated H1R gene expression before pollen 
exposure and then inhibited pollen-induced nasal symptoms 
and pollen-induced up-regulation of H1R gene expression in the 
nasal mucosa of patients with pollinosis (4). Because, histamine 
signaling is regulated by the levels of H1R expression (5, 6), it 
is suggested that prophylactic administration of antihistamines 
inhibited both basal transcription and histamine-induced tran-
scriptional activation of H1R in the nasal mucosa, resulting in 
summative suppression of nasal symptoms during peak pollen 
season in patients with pollinosis. 
Intranasal corticosteroid (INCS) is also effective for the 
treatment of allergic rhinitis (7). A recent randomized place-
bo-controlled trial demonstrated that pre-seasonal prophylactic 
administration of INCS prevented the worsening of nasal symp-
toms during peak pollen season in patients with pollinosis (8). 
Accordingly, in the present study, we examined whether INCS 
down-regulates H1R gene expression in the nasal mucosa of 
healthy participants in vivo. We then examined whether dexa-
methasone, a corticosteroid inhibits basal and histamine-in-
duced up-regulation of H1R mRNA, and histamine-induced 
phosphorylation of protein kinase Cδ (PKCδ) and extracellular 
signal-regulated kinase (ERK) in HeLa cells in vitro.
PARTICIPANTS AND METHODS
Participants
We enrolled 16 healthy participants with no history of allergic 
rhinitis (10 males, 6 females ; 22-26 years old ; mean age : 24.2 
years). Participants received intranasal doses of 200 µg of 
mometasone furoate in the right nostril using a nasal spray de-
vice once daily for a week. Nasal mucosa samples were obtained 
under local anesthesia with 4% lidocaine by scraping the surface 
of the inferior nasal concha with a small spatula before and after 
INCS administration for 7 days, as previously described (6). This 
study was approved by the Ethical Committee of Tokushima 
University Hospital (UMIN6094), and written informed consent 
was obtained from each patient before inclusion in the study. 
Real-time quantitative RT-PCR
Nasal mucosa samples of participants were frozen in RNAl-
ater® (Applied Biosystems, Foster City, CA, USA) and stored 
at -80℃ until use. Total RNA was isolated using the RNAque-
ous-Micro Kit (Applied Biosystems) following the manufactur-
er’s instructions. RNA samples were reversed-transcribed to 
produce cDNA using a High Capacity cDNA Reverse Transcription 
The Journal of Medical Investigation    Vol. 67  2020
311
　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　
Received for publication May 17, 2020 ; accepted June 14, 2020.
Address correspondence and reprint requests to Yoshiaki Kitamura, 
Department of Otolaryngology, Institute of Biomedical Sciences, Tok-
ushima University Graduate School, 3-18-15 Kuramoto, Tokushima 
770-8503, Japan and Fax : +81-88-633-7170.
312 Y. Kitamura, et al.  INCS suppresses H1R gene expression
Kit (Applied Biosystems). TaqMan primers and probes were 
designed using Primer Express primer design software (Applied 
Biosystems). The sequences of the H1R primers were : sense 
primer, 5’-CAGAGGATCAGATGTTAGGTGATAGC-3’ ; an-
tisense primer, 5’-AGCGGAGCCTCTTCCAAGTAA-3’. The 
sequence of the probe was as follows : FAM-CTTCTCTCGAAC-
GGACTCAGATACCACC-TAMRA. The PUM1 primer and 
probe kit (Hs 00206469-m1, Applied Biosystems) was used as an 
internal standard. 
HeLa cells were cultured at 37℃ under a humidified 5% CO2 
atmosphere in Minimal Essential Medium-α (α-MEM) contain-
ing 8% fetal calf serum and 1% antibiotic-antimycotic (Invitro-
gen). HeLa cells were cultured to 70% confluence in 6-well dishes 
then serum-starved for 24 h and treated with dexamethasone at 
doses of 0.1, 1, and 10 µM for 1 h. Cells were then treated with 
100 µM histamine for 3 h then cells harvested with 700 µl of 
RNAiso Plus (Takara Bio Inc. Kyoto Japan) and total RNA and 
cDNA were prepared by a previously reported method (9). For 
real-time quantitative polymerase chain reaction (RT-qPCR), 
GAPDH levels were used to standardize the amount of starting 
material (Applied Biosystems), and data were expressed as the 
ratio of H1R mRNA to GAPDH mRNA. Transcripts were sub-
jected to a 40-cycle, 3-step PCR program using the GeneAmp 
7300 Sequence Detection System (Applied Biosystems). The 
size and reaction specificity of the amplicon were confirmed by 
agarose gel electrophoresis. Identification of PCR products was 
carried out using a genetic analysis system (SEQ8000 ; Beck-
man Coulter, Inc., Fullerton, CA, USA).
Immunoblot analysis 
After HeLa cells were treated with 10 uM dexamethasone for 1 
h before stimulation with 100 uM histamine, whole cell extracts 
were prepared at various time points as described previously 
(9). Ten µg of total protein per sample was separated on a 10% 
SDS-PAGE gel then transferred to a nitrocellulose membrane 
(Bio-Rad). The membrane was briefly rinsed in Tris-buffered sa-
line with 0.1% Tween 20 (TBS-T) then incubated for 1 h at room 
temperature in TBS-T with 3% BSA (Sigma). The membrane 
was then incubated overnight at 4℃ with one of the following 
primary antibodies : PKCδ (C-20), sc-937, 1:1000 ; ERK (K-23), 
sc-94, 1:1000 ; phospho-ERK (E-4), sc-7383, 1:1000, (Santa Cruz 
Biotechnology) ; phospho-PKCδ (Tyr311), #2055S, 1:500 (Cell 
Signaling). The membrane was then incubated in the appro-
priate secondary antibody (goat anti-rabbit IgG (H ± L)-HRP 
conjugate (#170-6515, 1:10,000, Bio-Rad) or Immun-Star goat 
anti-mouse-HRP conjugate (#170-5047, 1:10,000, Bio-Rad) and 
proteins visualized using Immobilon Western Chemilumines-
cent HRP substrate (Millipore).
Statistical analysis
Data are presented as means ± SEM. Statistical analyses 
were performed with unpaired t tests or one-way ANOVA using 
Dunnett’s test by the GraphPad Prismsoftware (GraphPad-
SoftwareInc., LaJolla, CA). P values of < 0.05 were considered 
statistically significant.
RESULTS
Effect of INCS administration on H1R mRNA levels in the nasal 
mucosa of healthy participants.
Levels of H1R mRNA in the nasal mucosa of healthy partic-
ipants receiving INCS once a day for a week were significantly 
decreased, compared to those before INCS administration (Fig. 
1). No localized adverse events, such as nasal burning or epistax-
is were observed.
Effects of dexamethasone on basal and histamine-induced H1R 
mRNA levels, and histamine-induced phosphorylation of PKCδ and 
ERK in HeLa cells.
HeLa cells expresses H1R endogenously (10). Treatment 
with dexamethasone at a dose of 1 μM significantly decreased 
basal levels of H1R mRNA in HeLa cells (Fig. 2A). Histamine 
significantly increased levels of H1R mRNA in HeLa cells and 
dexamethasone at doses from 0.1-10 μM significantly suppressed 
histamine-induced up-regulation of H1R mRNA (Fig. 2B). 
Stimulation with histamine also increased phosphorylation of 
PKCδ and ERK in HeLa cells (11). Immunoblot analysis showed 
that dexamethasone did not suppress histamine-induced PKCδ 
phosphorylation (Fig. 3). On the other hand, dexamethasone 
suppressed histamine-induced ERK phosphorylation in HeLa 
cells (Fig. 3).
DISCUSSION
In the present study, we showed that INCS administration 
for a week decreased levels of H1R mRNA in the nasal mucosa 
of healthy participants with no history of allergic rhinitis. The 
finding suggests that INCS down-regulates H1R gene expres-
sion in the nasal mucosa in vivo. We also showed that dexa-
methasone decreased basal levels of H1R mRNA in HeLa cells, 
suggesting that corticosteroid suppressed basal transcription 
of H1R. Corticosteroids are effective drug for treating allergic 
diseases, and the different mechanisms by which steroids exert 
their anti-allergic properties have been described (12). Recently, 
INCS was used for a prophylactic treatment of pollinosis (13) 
and a double-blinded, randomized, and placebo-controlled study 
showed that prophylactic administration of INCS before pollen 
dispersion was more effective than post-onset treatment or a 
placebo (14). Taken together, it is suggested that pre-seasonal 
INCS administration prevents the forthcoming type-1 allergy 
symptoms due to its suppression of basal transcription of H1R 
in the nasal mucosa. Prophylactic INCS administration has also 
been suggested to suppress priming effect, minimal persistent 
Figure 1.　Effect of intranasal corticosteroid (INCS) administration 
on histamine H1 receptor (H1R) mRNA levels in the nasal mucosa of 
healthy participants.  
The expression of H1R mRNA in the nasal mucosa of 16 healthy 
participants receiving INCS once a day for one week was significantly 
lower than that before administration. Data are presented as 
means ± SEM.  *p < 0.05 versus pre-INCS administration.
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inflammation and eosinophil migration in the nasal mucosa of 
patients with allergic rhinitis (15).  
In the present study, we showed that dexamethasone also sup-
pressed histamine-induced up-regulated H1R gene expression 
in HeLa cells, as reported previously (10). We also showed that 
immunoblot analysis showed that dexamethasone suppressed 
histamine-induced ERK phosphorylation, but not PKCδ phos-
phorylation in HeLa cells. The PKCδ / ERK / poly (ADP-ribose) 
polymerase-1 (PARP-1) signaling pathway was involved in his-
tamine-induced up-regulation of H1R gene expression in HeLa 
cells after PKCδ and ERK activation by phosphorylation (11). 
Therefore, it is suggested that ERK is a target molecule of dexa-
methasone to suppress transcriptional activation of H1R. 
Because we previously showed that corticosteroids suppressed 
histamine-induced transcriptional activation of H1R in the 
nasal mucosa of a rat model of allergic rhinitis (16), it is assumed 
that INCS would suppress histamine-induced up-regulation of 
H1R in the nasal mucosa of patients with pollinosis. Although 
the hypothesis should be proved in the further study, the find-
ings in the present study suggest that prophylactic administra-
tion of INCS before pollen dispersion suppresses transcriptional 
activation of H1R, as well as its basal transcription in the nasal 
mucosa, resulting in the prevention of worsening of nasal symp-
tom during peak pollen season in patients with pollinosis. 
In conclusion, we showed INCS down-regulated H1R gene 
expression in the nasal mucosa of healthy participants with no 
history of allergic rhinitis. We also showed that dexamethasone, 
a corticosteroid inhibited basal transcription and transcriptional 
activation of H1R in HeLa cells through its suppression of ERK 
phosphorylation in the PKCδ / ERK / PARP-1 signaling involved 
in H1R gene transcription. These data suggest that pre-seasonal 
prophylactic administration of INCS suppresses both basal and 
pollen-induced up-regulation of H1R gene expression in the 
nasal mucosa of the patients with pollinosis, leading to preven-
tion of the exacerbation of nasal symptoms during peak pollen 
season.
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Figure 3.　Effects of dexamethasone on histamine-induced phos-
phorylation of PKCδ and ERK in HeLa cells.
HeLa cells were serum-starved for 24 h. The cells were treated 
with 10 µM dexamethasone for 1 h before stimulation with 100 µM 
histamine and phosphorylation levels of PKCδ and ERK at various 
timepoints were determined using immunoblot analysis. Data show 
that in the presence of dexamethasone, p-ERK density decreased as 
time goes by, while p-PKC increased after treatment with histamine. 
p-PKCδ : phospho PKCδ ; t-PKCδ : total PKCδ ; p-ERK : phospho 
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Figure 2.　Effects of dexamethasone on basal (A) and histamine-induced (B) H1R mRNA levels in HeLa cells.
(A) HeLa cells were treated with dexamethasone (1 µM) for 1 h. (B) HeLa cells were treated with 
dexamethasone (0.1-10 µM) for 1 h before 100 µM histamine treatment for 3 h. Then, the cells were harvested 
and total RNA was isolated. Amount of H1R mRNA was determined by quantitative RT-PCR. Data are 
presented as means ± SEM (n = 3-9). ★★, p < 0.01 versus histamine ; ##, p < 0.01, #, p < 0.05 versus control.
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